Rocket Lab’s 63% Revenue Surge and $2.2 Billion Backlog Fail to Arrest 34% Monthly Selloff
Published on 07/21/2026 at 15:23 | Redaktion boerse-global.de
Shares of Rocket Lab clawed back 3.14% on Tuesday to €59.20, a modest relief after one of the most brutal selloffs in the stock’s recent history. Over the preceding 30 days the equity had lost 32.57% of its value, pushing the 14-day relative strength index to 31.7 — a territory that often foreshadows a bounce. But the rebound alone does not signal a trend reversal; the company’s improving operational metrics stand in stark contrast to a market that has turned sharply skeptical of the space sector.
Rocket Lab’s business performance has rarely looked stronger. First-quarter revenue hit $200.35 million, a 63.4% year-over-year gain that topped analyst expectations. The net loss per share of $0.07 matched consensus precisely, while gross margin expanded to a record 38%. The order backlog swelled to $2.2 billion, and management guided for second-quarter revenue between $225 million and $240 million with gross margin of 38% to 40%. Even so, the stock has shed about a third of its value in a month.
The main catalyst for the selloff was twofold. First, the much-anticipated debut of Rocket Lab’s new Neutron launch vehicle was pushed back to the fourth quarter of 2026 — a delay that disappointed investors who had hoped for an earlier commercial rollout. Second, the company announced a $8 billion acquisition of Iridium Communications, paying $54 per share in a deal that would create a vertically integrated space-infrastructure provider. Markets reacted with unease, fearing shareholder dilution and questioning the strategic fit, especially given Iridium’s annual revenue of $872 million versus SpaceX’s $11.4 billion. The Iridium transaction is not expected to close before mid-2027.
Should investors sell immediately? Or is it worth buying Rocket Lab?
A bright spot emerged amid the gloom. Rocket Lab successfully conducted a full-duration static fire test of the AVac engine, designed for the vacuum version of Neutron. The milestone strengthens the technical case for the reusable rocket, but it failed to lift sentiment in a market that has rotated away from space names.
Insider selling added to the pressure. Over the past 90 days, company insiders disposed of shares worth a combined $362.8 million. Chief executive Peter Beck sold roughly 1.3 million shares between July 6 and 8 under a pre-arranged trading plan, at prices ranging from about $82 to $102. Other top executives, including chief financial officer Adam Spice and director Alexander Slusky, also unloaded significant positions in May and June. Institutional activity was more mixed. The Swiss National Bank boosted its stake by 17.8% in the first quarter to over 1.41 million shares, while CalPERS increased its holdings by 8.6% to about 796,000 shares. Other funds such as Amova Asset Management trimmed their positions.
Retail sentiment has cratered. On Polymarket, the probability that the stock would fall to $64 in July once stood at 88% — though the platform’s community has been right only 28.6% of the time in past bets. On Reddit, a sentiment metric from AOL dropped from a high of 85 near the Iridium announcement to a low of 18 in mid-July. Analysts on Wall Street remain divided: Piper Sandler started coverage with a neutral rating, while Citizens and Roth Capital maintain bullish targets, arguing the Iridium deal positions Rocket Lab as a premier vertical player. The average price target still stands at $110.18, implying substantial upside from current levels, but many strategists warn that further declines could occur before a buying opportunity emerges.
Two events will shape the months ahead: the Neutron maiden flight, now backed by a successful engine test, and the completion of the Iridium acquisition, which is not expected until at least the middle of next year. Until then, the stock’s annualized 30-day volatility of 95.66% suggests the swings are far from over. Rocket Lab has already executed 88 launches to date and was named one of seven companies in the U.S. Space Force’s NSSL Phase 3 Lane 1 program, which saw its total contract ceiling raised by $11.4 billion to $17 billion. Yet even that news failed to stem the decline — the stock fell 2.7% on the day of the announcement to a three-month low. The disconnect between operational strength and market sentiment has rarely been wider.
Ad
Rocket Lab Stock: New Analysis - 21 July
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
